Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01044745Phase 2Terminated
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
PrincipalinvestigatorStart date: 2009-12-10
NCT00816413Phase 1/2Withdrawn
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaGraft vs Host Disease+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesChronic Myeloproliferative Disorders+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Contiguous Stage II Mantle Cell LymphomaNoncontiguous Stage II Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+2 more
Similarity Score1%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Chronic Myeloproliferative DisordersLeukemiaLymphoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host DiseaseLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Myelodysplastic SyndromesGraft vs Host DiseaseLymphoma
Similarity Score1%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Graft vs Host DiseaseLeukemiaLymphoma
Similarity Score1%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01044745Phase 2PrincipalInvestigator

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
Terminated
NCT00816413Phase 1/2PrincipalInvestigator

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Withdrawn

All 2 trials loaded